Home » Authors » Mark McCarty

Articles by Mark McCarty

HSAs: fairly traditional coverage – or 'extra dollars for the rich'?

June 30, 2006

By Mark McCarty

FDA's Tillman says product lifecycle model is 'outdated'

June 29, 2006

By Mark McCarty

Hearing debates U.S. potential as payer for medical tourism

June 28, 2006

By Mark McCarty

FDA's Tillman says product lifecycle model is 'outdated'

June 27, 2006

By Mark McCarty

HIT, EHRs not big hit with all, according to hearing debate

June 26, 2006

By Mark McCarty

Washington roundup: Health courts get broad support as hospital pilot project is eyed

June 26, 2006

By Mark McCarty

VHA in crosshairs of data theft, electronic health record tech

June 23, 2006

By Mark McCarty

P4P demonstration project offers hope for U.S. healthcare

June 22, 2006

By Mark McCarty

MDMA annual meeting: CMS execs lobby for new IPPS rules opposed by device sector

June 20, 2006

By Mark McCarty

MDMA annual meeting: Legal, regulatory landscape for patent claims is in flux

June 19, 2006

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...